ESPR icon

Esperion Therapeutics

124 hedge funds and large institutions have $104M invested in Esperion Therapeutics in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 37 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

20% less capital invested

Capital invested by funds: $129M → $104M (-$25.5M)

24% less funds holding

Funds holding: 164124 (-40)

62% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 61

Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.51M
Puts
$1.41M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$595K
27
$579K
28
$465K
29
$447K
30
$439K
31
$420K
32
$413K
33
$353K
34
$351K
35
$347K
36
$334K
37
$311K
38
$309K
39
$284K
40
$280K
41
$273K
42
$271K
43
$261K
44
$256K
45
$252K
46
$224K
47
$209K
48
$177K
49
$172K
50
$163K